IL3 and acute lymphoblastic leukemia: In the present study, we characterized a novel functional JAK1 S646P mutation in ALL identified by WES, which was able to activate JAK-STAT and MAPK-ERK signaling pathways, and drive IL-3-independent growth of BaF3 cells.